ReferWell key facts
as of Oct 2026- Developer of a cloud-based platform designed to solve the last-mile problem of healthcare.
- ReferWell is valued at approximately $37.9M as of Oct 2026 (last reported valuation).
- It has raised $17.1M; the latest was Later Stage VC ($7.9M) in Aug 2025.
- Notable investors include Connecticut Innovations, New York Angels, Viewside Capital Partners, Zeal Tech, Blueprint Health — 7 tracked in total.
- Status: Privately Held (backing).
ReferWell's last reported valuation, Aug 2025. Nothing priced has surfaced since.
- ·Watch ReferWell: the Monday email on marks, rounds and moves
ReferWell funding rounds
No funding rounds for ReferWell are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
ReferWell valuation
ReferWell's last reported valuation was $37.9 million in Aug 2025. No priced round, secondary trade or fund mark has surfaced since.
ReferWell investors
7 investors are on record for ReferWell, including Connecticut Innovations, New York Angels, Viewside Capital Partners and Zeal Tech.
About ReferWell
Developer of a cloud-based platform designed to solve the last-mile problem of healthcare. The company manages all aspects of scheduling the care transition to close care gaps, enabling the healthcare providers and networks to gain increased revenues and lower costs while patients get an improved experience and healthier outcomes.
- Sector
- Healthcare
- HQ
- Stamford, CT, United States
- Founded
- 2014
- Employees
- 55
- Website
- engage.referwell.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.